139 related articles for article (PubMed ID: 8279779)
1. High dose intensity chemotherapy without bone marrow support: role of granulocyte-macrophage colony-stimulating factor.
Venturini M; Del Mastro L; Ardizzoni A; Sertoli MR; Mariani GL; Pennucci MC; Garrone O; Silvestro S; Addamo GF; Queirolo P
Ann N Y Acad Sci; 1993 Nov; 698():389-97. PubMed ID: 8279779
[No Abstract] [Full Text] [Related]
2. Chemotherapy dose-escalation with hemopoietic growth factor support in ovarian cancer.
Willemse PH; Boonstra H; de Vries EG
Semin Oncol; 1994 Dec; 21(6 Suppl 16):44-50. PubMed ID: 7528450
[No Abstract] [Full Text] [Related]
3. Granulocyte-macrophage colony-stimulating factor and marrow transplantation.
Sauter C
N Engl J Med; 1988 Sep; 319(13):870-1. PubMed ID: 3045556
[No Abstract] [Full Text] [Related]
4. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.
Brandt SJ; Peters WP; Atwater SK; Kurtzberg J; Borowitz MJ; Jones RB; Shpall EJ; Bast RC; Gilbert CJ; Oette DH
N Engl J Med; 1988 Apr; 318(14):869-76. PubMed ID: 3281007
[TBL] [Abstract][Full Text] [Related]
5. Prevention and therapy of neutropenia in elderly patients.
Rosti G; Kopf B; Cariello A; Monti M; Dazzi C; Papiani G; Giovanis P; De Giorgi U; Marangolo M
Crit Rev Oncol Hematol; 2003 Jun; 46(3):247-53. PubMed ID: 12791424
[TBL] [Abstract][Full Text] [Related]
6. Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer.
Ho AD; Glück S; Germond C; Sinoff C; Dietz G; Maruyama M; Corringham RE
Leukemia; 1993 Nov; 7(11):1738-46. PubMed ID: 7901454
[TBL] [Abstract][Full Text] [Related]
7. High-intensity chemotherapy with hematopoietic support in breast cancer.
Crown J; Vahdat L; Fennelly D; Francis P; Wasserheit C; Hudis C; Kritz A; Schneider J; Hamilton N; Gilewski T
Ann N Y Acad Sci; 1993 Nov; 698():378-88. PubMed ID: 7506505
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.
Shpall EJ; Jones RB; Bearman SI; Franklin WA; Archer PG; Curiel T; Bitter M; Claman HN; Stemmer SM; Purdy M
J Clin Oncol; 1994 Jan; 12(1):28-36. PubMed ID: 7505806
[TBL] [Abstract][Full Text] [Related]
9. Colony-stimulating factors for adjunctive therapy of infections in neutropenic cancer patients.
Mayordomo JI; Rivera F; Cortes-Funes H
Support Care Cancer; 1995 Jan; 3(1):84-5. PubMed ID: 7535169
[No Abstract] [Full Text] [Related]
10. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation.
Peters WP; Kurtzberg J; Atwater S; Borowitz M; Rao M; Currie M; Gilbert C; Shpall EJ; Jones RB; Ross M
Prog Clin Biol Res; 1990; 338():121-8. PubMed ID: 2189135
[No Abstract] [Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor (GM-CSF) in the management of cancer.
Fan D; O'Brian CA; Ioannides CG; Clyne RK
In Vivo; 1991; 5(6):571-7. PubMed ID: 1810441
[TBL] [Abstract][Full Text] [Related]
12. Use of granulocyte-macrophage colony stimulating factor (GM-CSF) to support intensive chemotherapy.
Klingemann HG
Prog Clin Biol Res; 1990; 354B():211-8. PubMed ID: 2236167
[No Abstract] [Full Text] [Related]
13. Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial.
Vose JM; Pandite AN; Beveridge RA; Geller RB; Schuster MW; Anderson JE; LeMaistre CF; Ahmed T; Granena A; Keating A; Fernandez Ranada JM; Stiff PJ; Tabbara I; Longo W; Copelan EA; Nichols C; Smith A; Topolsky DL; Bierman PJ; Lebsack ME; Lange M; Garrison L
J Clin Oncol; 1997 Apr; 15(4):1617-23. PubMed ID: 9193361
[TBL] [Abstract][Full Text] [Related]
14. [High dose chemotherapy in malignant gliomas using autologous bone marrow transplantation and GM-CSF: granulocyte-macrophage colony stimulating factors].
Yamashita J; Kawamura T; Shoin K
No Shinkei Geka; 1990 Apr; 18(4):329-38. PubMed ID: 2197571
[No Abstract] [Full Text] [Related]
15. Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF.
Ballestrero A; Ferrando F; Garuti A; Basta P; Gonella R; Stura P; Mela GS; Sessarego M; Gobbi M; Patrone F
J Clin Oncol; 1999 Apr; 17(4):1296. PubMed ID: 10561192
[TBL] [Abstract][Full Text] [Related]
16. The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy.
Elias AD; Ayash L; Tepler I; Wheeler C; Schwartz G; Mazanet R; Schnipper L; Frei E; Antman K
J Hematother; 1993; 2(3):377-82. PubMed ID: 7522891
[TBL] [Abstract][Full Text] [Related]
17. Dose intensity in breast cancer chemotherapy--the way ahead?
Tattersall MH
Ann Oncol; 1994 Oct; 5(8):674-5. PubMed ID: 7530034
[No Abstract] [Full Text] [Related]
18. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human granulocyte-macrophage colony-stimulating factor for the intensification of cytostatic treatment in advanced cancer.
Schmid L; Thürlimann B; Müller M; Senn HJ
Recent Results Cancer Res; 1991; 121():173-81. PubMed ID: 1857857
[No Abstract] [Full Text] [Related]
20. The value of dose intensification of standard chemotherapy for advanced breast cancer using colony-stimulating factors alone.
Clemons M; Gharif R; Howell A
Cancer Treat Rev; 1998 Jun; 24(3):173-84. PubMed ID: 9767733
[No Abstract] [Full Text] [Related]
[Next] [New Search]